Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
Alamar Biosciences, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence, with strong management execution.
Why it matters: High Consumable Growth.
2 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 1d ago
Reported figures for Alamar Biosciences, Inc. — research only, not investment advice.
Updated
What happened recently for Alamar Biosciences, Inc. (ALMR) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$33.16
Market cap
$2.30B
Profitable
No
Revenue $26.04M
Net income
$-21.33M
FY Jul 18, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Alamar Biosciences, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Alamar Biosciences, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.